Brief: Illumina And Tempus Partner To Drive The Future Of Precision Medicine Through Genomic Ai Innovation
April 15 (Reuters) - Illumina Inc ILMN.O: ILLUMINA AND TEMPUS PARTNER TO DRIVE THE FUTURE OF PRECISION MEDICINE THROUGH GENOMIC AI INNOVATION Source text: ID:nPn5qzggwa Further company coverage: ILMN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Illumina
See all newsRoche launches Axelios gene sequencer in a bid to loosen Illumina's grip (updated)
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner